Differences between revisions 5 and 6
Revision 5 as of 2006-11-17 15:29:14
Size: 2902
Editor: lfrq80
Comment: Reorganizing the MIM pages
Revision 6 as of 2006-11-17 21:02:49
Size: 2890
Editor: lfrq80
Comment:
Deletions are marked like this. Additions are marked like this.
Line 8: Line 8:
|| '''Use Case Name''' : AssistedLayout || || '''Use Case Name''' : ../AssistedLayout ||
Line 28: Line 28:
 1. The system performs AutoDrawBioPax  1. The system performs ../AutoDrawBioPax
Line 31: Line 31:
 1. The user performs EditAnnotation  1. The user performs ../EditAnnotation
Line 55: Line 55:
Shared MimEditorUseCaseComments Shared ../MimEditorUseCaseComments
Line 57: Line 57:
This builds on the AutoDrawBioPax and EditAnnotation use cases. This builds on the ../AutoDrawBioPax and ../EditAnnotation use cases.
Line 60: Line 60:

Molecular_Interaction_Maps

Use Case Name : ../AssistedLayout

For Feature : MIMEditor

Editors: DavidKane

TableOfContents([2])

Summary

A user wants to edit a map using an existing BioPAX document as a starting point.

Step-by-Step User Action

  1. User selects a BioPAX document to edit
  2. The system performs ../AutoDrawBioPax

  3. The user edits the map by repositioning objects on the map
  4. The user edits the map by adding features
  5. The user performs ../EditAnnotation

  6. The user edits the map by removing features and annotations
  7. Steps 3, 4, 5 and 6 are repeated as necessary
  8. The user saves the map
  9. When the map is re-opened all of the layout changes are preserved

Visual Aides

Requirements for Cytoscape

TBD

Importance

For Kohn maps, which are often used as communication documents, manual layout is important for achieving the desired clarity in the document. However, manual layout can be very tedious, and so having tools to expedite the process are important.

Other Examples

Comments

Shared ../MimEditorUseCaseComments

This builds on the ../AutoDrawBioPax and ../EditAnnotation use cases.

PageComment2

Molecular_Interaction_Maps/AssistedLayout (last edited 2009-02-12 01:03:09 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux